Ctt Pharmaceutical Holdings annual stock-based compensation
2007
2008
2009
2010
2011
2012
2013
2014
Ctt Pharmaceutical Holdings Stock-Based Compensation Growth & History (CTTH)
Ctt Pharmaceutical Holdings's stock-based compensation was $308,439 for fiscal 2014.
View full Ctt Pharmaceutical Holdings company overviewCtt Pharmaceutical Holdings annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2014 | 2014-12-31 | $308,439 | $308,439 | — |
| 2013 | 2013-12-31 | $0 | −$42,268 | — |
| 2012 | 2012-12-31 | $42,268 | −$113,128 | −72.80% |
| 2011 | 2011-12-31 | $155,396 | $988 | +0.64% |
| 2010 | 2010-12-31 | $154,408 | −$24,813 | −13.84% |
| 2009 | 2009-12-31 | $179,221 | $2,794 | +1.58% |
| 2008 | 2008-12-31 | $176,427 | −$270,426 | −60.52% |
| 2007 | 2007-12-31 | $446,853 | — | — |
Ctt Pharmaceutical Holdings quarterly stock-based compensation
Q2.10
Q3.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.15
Q2.15
Q3.15
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q3 2015 | 2015-09-30 | $46,408 | — | — |
| Q2 2015 | 2015-06-30 | $49,166 | — | — |
| Q1 2015 | 2015-03-31 | $43,650 | — | — |
| Q4 2013 | 2013-12-31 | $0 | $0 | — |
| Q3 2013 | 2013-09-30 | $0 | $0 | — |
| Q2 2013 | 2013-06-30 | $0 | $0 | — |
| Q1 2013 | 2013-03-31 | $0 | −$42,268 | — |
| Q4 2012 | 2012-12-31 | $0 | $0 | — |
| Q3 2012 | 2012-09-30 | $0 | $0 | — |
| Q2 2012 | 2012-06-30 | $0 | −$155,396 | — |
| Q1 2012 | 2012-03-31 | $42,268 | $42,268 | — |
| Q4 2011 | 2011-12-31 | $0 | — | — |
| Q3 2011 | 2011-09-30 | $0 | −$133,228 | — |
| Q2 2011 | 2011-06-30 | $155,396 | $144,806 | +1367.38% |
| Q1 2011 | 2011-03-31 | $0 | — | — |
| Q3 2010 | 2010-09-30 | $133,228 | — | — |
| Q2 2010 | 2010-06-30 | $10,590 | — | — |
Ctt Pharmaceutical Holdings stock-based compensation trends
Over the last five fiscal years, Ctt Pharmaceutical Holdings's stock-based compensation increased from $179,221 to $308,439, a change of $129,218. The latest reported quarter, Q3 2015, shows $46,408.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ctt Pharmaceutical Holdings source filings ↗